COMMUNIQUÉS West-GlobeNewswire

Faithful Fertility Collective Launches 'Miracle in the Making' Program to Support Natural Conception
06/05/2025
Introducing a New Path to Parenthood: "Miracle in the Making" Madison, Wisconsin, May 06, 2025 (GLOBE NEWSWIRE) -- Faithful Fertility Collective , the leader in holistic, faith-centered fertility coaching, is thrilled [...]
Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25
06/05/2025
Interim financial results, H1 2024/25 1 October 2024 - 31 March 2025 Coloplast delivered 6% organic growth in Q2, impacted by the product recall in Interventional Urology and a softer quarter in Ostomy Care. Q2 EBIT [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
06/05/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 6 May 2025 at 18.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
RapidPulse Announces Patient Enrollment Initiated in Pivotal Ischemic Stroke Study
06/05/2025
MIAMI, May 06, 2025 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a Delaware corporation headquartered in Miami, Florida focused on improving the treatment success rate for acute ischemic stroke (AIS), announced patient [...]
Pasithea Therapeutics Announces Pricing of $5 Million Public Offering
06/05/2025
MIAMI, May 06, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics, Corp. (“Pasithea,” or the “Company”) (Nasdaq: KTTA; KTTAW), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
06/05/2025
Communiqué de Presse Information relative au nombre total de droits de vote e t d’actions composant le capital social Dijon, le 06 mai 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
06/05/2025
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 06 mai 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025
06/05/2025
Data showed improvements across several key measures of visual function, including low luminance visual acuity and microperimetry Laru-zova was generally well-tolerated by DAWN participants at 6 months LONDON and [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
06/05/2025
Déclaration de transactions sur actions propres Paris, France (6 mai 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que le 29 avril 2025, les [...]
EssilorLuxottica: Disclosure of transactions in own shares
06/05/2025
Disclosure of transactions in own shares Paris, France (May 6, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2024, EssilorLuxottica declares that on [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
06/05/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 6 mai 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général [...]
MyoKardia Announces Inaugural MyoSeeds™ Research Grants Program Awardees
07/05/2019
Three Researchers Awarded $250,000 Each to Advance Independent Research in Cardiac Diseases SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- MyoKardia, a clinical-stage biopharmaceutical company pioneering [...]
VAXIL: SHARE CONSOLIDATION
06/05/2025
Not for distribution by US newswire or in United States TORONTO, May 06, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“ Vaxil ” or the “ Company ”) (TSX VENTURE: VXL), is pleased to make the following updates regarding the [...]
Opus Genetics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OPGx-LCA5 Gene Therapy Candidate
06/05/2025
- FDA RMAT designation recognizes encouraging early data from Opus’ Phase 1/2 trial in patients with LCA5, an ultra-rare inherited retinal disease RESEARCH TRIANGLE PARK, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Opus [...]
Galimedix Therapeutics completes single ascending dose part of Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator
06/05/2025
GAL-101 well tolerated; excellent safety and pharmacokinetic profile strongly supports oral administration Next arms of study, including multiple ascending dose (MAD), underway and expected to complete in late 2025 [...]
Cogent Biosciences Reports First Quarter 2025 Financial Results
06/05/2025
Three Registration-Directed Top-line Data Readouts Remain on Track in 2025: SUMMIT in NonAdvanced SM expected in July, APEX in Advanced SM expected in second half of the-year and PEAK in GIST expected by end of year [...]
BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study
06/05/2025
CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction (HFrEF) and Elevated Markers of Cardiac Stress Dr. Amish Raval, Professor of [...]
Actuate Therapeutics Announces Statistically Significant Topline Results from Global Phase 2 Trial of Elraglusib in First-Line Treatment of Metastatic Pancreatic Cancer
06/05/2025
Topline data shows statistically significant improvement in overall survival in elraglusib plus GnP combination arm versus GnP control arm Elraglusib/GnP combination arm demonstrated substantial improvement in median [...]
Pacira BioSciences to Present 3-Year Safety and Efficacy Data of PCRX-201 Following Single Intra-Articular Injection for Moderate-to-Severe Knee Osteoarthritis
06/05/2025
-- Data will be featured at EULAR Annual Congress – BRISBANE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid [...]

Pages